MedTrace Logo

LIKEST Study: Lipocet® in Adults With Primary Knee Osteoarthritis Grade 3-4

NCT06134115 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 60

Last updated 2023-11-18

No results posted yet for this study

Summary

The purpose of this study is to assess the safety, tolerability and efficacy of Lipocet® (food supplement) in patients with primary knee osteoarthritis grade 3 - 4

Conditions

  • Primary Knee Osteoarthritis Grade 3 - 4

Interventions

DIETARY_SUPPLEMENT

Lipocet® (food supplement)

1 sachet, 10 ml corresponding to 1500 mg of Cetylated fatty acids

DIETARY_SUPPLEMENT

Lipocet Placebo

Lipocet Placebo matching to Lipocet

Sponsors & Collaborators

  • NEA Clinical S.r.l.

    collaborator UNKNOWN

  • Pharmanutra S.p.a.

    lead INDUSTRY

Principal Investigators

  • Maria Sole Rossato · Pharmanutra S.p.a.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-19
Primary Completion
2023-03-06
Completion
2023-05-18

Countries

  • Georgia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06134115 on ClinicalTrials.gov